Skip to main content

What immediate outcomes can be expected from these data?

Access to the genomic data is controlled by the H3Africa Data and Biospecimen Access Committee (DBAC), which oversees data access after submission to the European Genome-Phenome Archive (EGA). GenCoE Leadership and Sample Providers also play a role in facilitating access before public release, ensuring compliance with ethical and regulatory requirements. The Sample Providers are free to make decisions on opening access to other academic groups or individuals in Africa; however, there will be restrictions in place for sharing with pharmaceutical companies that are not PAGRA partners for two years from the time the final WGS data is generated.

Order
4